The West Midlands is home to an established life sciences sector, particularly in medical technologies and translational medicine.
Strong collaborative partnerships between industry, the NHS and academia means that the region has the second largest clinical trials base in Europe, several clinical and academic centres of excellence, and renowned expertise in areas of advanced manufacturing including AI, automation and robotics.
Yet there are many more opportunities that we can realise within the West Midlands. Globally, the life sciences industry is expected to grow by $400 billion by 2023.
The Life Sciences Sector Plan, led by GBSLEP – which covers the West Midlands as part of the area’s Local Industrial Strategy – has identified this industry’s key strengths and opportunities. The Sector Plan also highlights the ways in which regional organisations can realise the full potential of this sector. These proposals include, but are not limited to:
As part of the West Midlands Local Industrial Strategy consultation, we want your feedback on the Life Sciences Sector Plan. The document will help to shape the future of our regional economy – and it is important that local organisations within the life sciences industry contribute to it.
Please read this document before submitting your comments and suggestions, click here to view.
Please send your comments and suggestions to: GBSLEP@birmingham.gov.uk
This document is part of the wider West Midlands Combined Authority’s consultation on the Industrial Strategy in conjunction with Greater Birmingham & Solihull Local Enterprise Partnership (GBSLEP), Coventry and Warwickshire Local Enterprise Partnership, and Black Country Consortium. It contains a four page executive summary of the plan and a more detailed version in the appendix: West Midlands Industrial Strategy consultation document.